Abstracts

Optimal Timing of Home-Based HIV Testing in Western Kenya

Achieving UNAIDS 90-90-90 goals for ART coverage will require new strategies for diagnosing and linking HIV positive persons to care. Home-based counselling and testing is one strategy that has been piloted and considered in sub-Saharan Africa. We used mathematical modelling to evaluate how HBCT campaigns can be improved, through the optimal-timing and enhancement of testing…

Narrowing the Gap in Life Expectancy for HIV+ Compared With HIV- Individuals

Survival of HIV-infected individuals has dramatically improved with combination antiretroviral therapy (ART). However, it is unclear how large a gap in life expectancy remains between HIV-infected and HIV-uninfected individuals, and how much of that gap is attributable to underlying differences in demographics or risk factors. We conducted a cohort study of HIV-infected adults who were…

Perception of Infectiousness in HIV-Infected Persons After Initiating ART: ACTG A5257

Antiretroviral therapy (ART)-induced viral suppression has been shown to reduce sexual transmission of HIV. Data for prevention of HIV transmission are strongest for heterosexual transmission. ART does not produce immediate or universal viral suppression, and perception of infectiousness (POI) may impact sexual risk taking. Changes in POI as a result of ART may have implications…

Breast Milk and In Utero HIV-1 Transmission Select for Unique Envelope Signatures

Despite improved prevention of mother-to-child transmission (MTCT) of human immunodeficiency virus-type 1 (HIV-1) in developing countries, 240,000 children acquired the virus in 2013.  HIV-1 MTCT can occur by three distinct routes:  in utero (transplacental passage), intrapartum, and postpartum through breastfeeding.  Disease progression can vary dramatically among these transmission modes, with infants infected in utero showing…

Impact of Option B+ on ART Uptake and Retention in Swaziland: A Stepped-Wedge Trial

Retaining HIV-infected pregnant and postpartum women in care is critical to prevent mother-to-child HIV transmission (PMTCT) and promote maternal health. New PMTCT approaches call for lifelong antiretroviral therapy (ART) for all HIV+ pregnant women (Option B+), a departure from strategies that used CD4 count to determine ART eligibility (Option A). Yet there are few implementation…